Moreover, ALDH1 has been used as a CSCs marker, and its expression is associated with tumors with greater invasiveness, metastases, treatment resistance, and worse prognosis in HNSCC (10). The gene discussed is ALDH1A1; the disease is head and neck squamous cell carcinoma.